The efficacy and cost-effectivennes of valacyclovir in cytomegalovirus prevention in solid organ transplantation
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F14%3A10282503" target="_blank" >RIV/00216208:11140/14:10282503 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1586/14737167.2014.965157" target="_blank" >http://dx.doi.org/10.1586/14737167.2014.965157</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1586/14737167.2014.965157" target="_blank" >10.1586/14737167.2014.965157</a>
Alternative languages
Result language
angličtina
Original language name
The efficacy and cost-effectivennes of valacyclovir in cytomegalovirus prevention in solid organ transplantation
Original language description
Prevention of cytomegalovirus infection using antiviral prophylaxis or the pre-emptive therapy approach is an integral part of management of patients after solid organ transplantation. Regarding renal transplantation, valacyclovir is currently the only antiviral agent recommended for prophylaxis as an alternative to valganciclovir. This review article discusses studies documenting the efficacy and safety of valacyclovir prophylaxis as well as those comparing valacyclovir with other prophylactic regimensor with pre-emptive therapy. Also addressed are the economic aspects supporting the cost-effectiveness of valacyclovir prophylaxis and demonstrating lower costs compared with other CMV preventive strategies.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/ED2.1.00%2F03.0076" target="_blank" >ED2.1.00/03.0076: Biomedical Centre of the Faculty of Medicine in Pilsen</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Expert Review of Pharmacoeconomics & Outcomes Research
ISSN
1473-7167
e-ISSN
—
Volume of the periodical
14
Issue of the periodical within the volume
6
Country of publishing house
GB - UNITED KINGDOM
Number of pages
9
Pages from-to
771-779
UT code for WoS article
000344931900003
EID of the result in the Scopus database
—